Company profile: Qointa
1.1 - Company Overview
Company description
- Provider of a compliant, validated eHealth platform for device-agnostic patient monitoring and coaching, enabling direct randomization into adaptive clinical trials. Offers digital transformation and software validation solutions, quality and regulatory support (QMS and risk management), medical device software development, and electronic data integrity services.
Products and services
- Medical Device Software Development: Regulatory-compliant service that engineers, designs, and validates software for medical devices, enforcing cybersecurity controls and documentation to ensure regulatory compliance
- Electronic Data Integrity Solutions: Risk-based service that delivers CSV frameworks, data integrity validation, and quality planning to safeguard compliance and security across various systems
- Quality Assurance and Regulatory Support: QMS-centric service that supplies guidance and support for implementing and maintaining quality management systems, regulatory compliance, and risk management in the MedTech industry
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Qointa
Frontida BioPharm
HQ: United States
Website
- Description: Provider of contract development and manufacturing services for biopharmaceutical companies, supporting scale-up and commercial manufacture of immediate and controlled release oral solid dose products, with capabilities to manufacture Highly Potent Active Ingredient products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frontida BioPharm company profile →
Euticals
HQ: Italy
Website
- Description: Provider of active pharmaceutical ingredients (APIs), custom synthesis, and fine chemicals. A leading player in the pharmaceutical and fine chemicals industry, with global-scale production, diversified manufacturing plants, and multiple technologies, delivering projects and products in fine chemicals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Euticals company profile →
Suazio
HQ: Belgium
Website
- Description: Provider of research and consultancy services offering customer insights, product value drivers, and economic value proposition services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Suazio company profile →
Lightship
HQ: United States
Website
- Description: Provider of services and solutions that make clinical trials more accessible for patients and providers to accelerate development of better therapies. Focused on improving health equity globally by offering studies that are more accessible and provide choice. Founded in 2018, it keeps people at the heart of its work and uses the latest innovations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lightship company profile →
START Research
HQ: United States
Website
- Description: Provider of oncology and biotechnology research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full START Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Qointa
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Qointa
2.2 - Growth funds investing in similar companies to Qointa
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Qointa
4.2 - Public trading comparable groups for Qointa
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →